Löfbacka, Viktor
Axelsson, Jan
Pilebro, Björn
Suhr, Ole B.
Lindqvist, Per
Sundström, Torbjörn http://orcid.org/0000-0002-9071-8993
Funding for this research was provided by:
Hjärt-Lungfonden (20160787)
Article History
Received: 9 September 2020
Accepted: 1 December 2020
First Online: 26 December 2020
Compliance with ethical standards
:
: The authors Pilebro, Lindqvist, and Sundström have a consultancy agreement with Pfizer. The author Suhr has consultancy agreements with Prothema, Akcea, and Intellia. All other authors have reported that they have no relationships to disclose that are relevant to the contents of this paper.
: The study was approved by the central ethical review board at Umeå University (Dnr: 06-084M, 2013-407-31M). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed written consent was obtained from each patient.